Amlodipine - A first-line agent in Hypertension Prem Aggarwal23 July 2020 10:45 AM ISTHypertension is a global health hazard and a leading cause of mortality and morbidity across the world. It is ranked third as a cause for...
Overpricing allegations on Fabiflu careless, unsubstantiated: Glenmark to DCGI Ruchika Sharma22 July 2020 4:45 PM ISTNew Delhi: Quashing allegations of 'false claims' and overpricing of COVID drug Favipiravir, drug major Glenmark Pharmaceuticals Ltd has recently...
Declining Kidney function linked to cognitive impairment in high BP patients Medha Baranwal20 July 2020 9:00 PM ISTUSA: Declining kidney function in hypertension patients may increase the risk for dementia and mild cognitive impairment (MCI), according to a...
Managing Difficult to Treat Hypertension with Newer ARBs Prof. Soumitra Kumar18 July 2020 12:15 PM ISTA considerable number of patients with hypertension remain resistant to treatment despite the many therapeutic options available today for...
Combination therapy for Hypertension: Olmesartan plus Azelnidipine or Olmesartan plus Amlodipine? Prem Aggarwal14 July 2020 12:45 PM ISTThe Protocol of Controlling Blood pressure (BP) in Hypertensive Patients is different in different parts of the world. Achieving adequate blood...
Women on beta blockers for high BP at increased risk of heart failure Dr. Kamal Kant Kohli14 July 2020 9:45 AM ISTDALLAS -- Beta blockers are medications that reduce high blood pressure and are prescribed for adults with hypertension, a leading cause of...
Black patients at higher risk of adverse outcomes including death after PCI Hina Zahid7 July 2020 6:54 PM ISTBlack patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major adverse outcomes, including death, compared to...
Captopril linked to more pulmonary events in COVID 19 affected Diabetics Dr.Niharika Harsha B7 July 2020 12:30 PM ISTCaptopril has been found to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE...
Ameliorating Glucose Intolerance with BP Control: Azelnidipine or Amlodipine? Prem Aggarwal2 July 2020 12:45 PM ISTStudy demonstrated that azelnidipine administration rather than amlodipine administration significantly ameliorated glucose intolerance and the...
Controlling Hypertension with Azilsartan: Recent Advances Uday Mahadeo Jadhav Jadhav26 Jun 2020 12:00 PM ISTAzilsartan is a newer, potent, and safe angiotensin II receptor blocker taking control over hypertension. It has played an essential role in changing...
JB Chemicals brings BP Lowering Drug, Azelnidipine (DHP CCB) to Indian market under brand name Azovas Meghna A Singhania20 Jun 2020 12:45 PM ISTNew Delhi: Known for its Calcium Channel Blockers (CCB) range for the management of hypertension, JB Chemicals and Pharmaceuticals Ltd has brought yet...
High BP in early pregnancy raises preeclampsia risk during pregnancy Medha Baranwal19 Jun 2020 2:03 PM ISTUSA: Going by the new definitions of hypertension, women in their early pregnancy having elevated blood pressure and, stage 1 and stage 2 hypertension...
